Skip to content
Riskpilot
← Back to search
Sign in
Get full access
OSENTI AS
AS
Active
Org 932106663
Jacob Aalls gate 49A, 0364
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2023 · 2 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
OSENTI AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
2M
3M
3M
0M
2023
0M
2024
3M
2025
EBITDA
NOK millions
1M
1M
1M
0M
0M
0M
2023
0M
0%
2024
1M
+100%
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
0
364
2 898
Staff expenses
−0
−7
−304
EBITDA
−21
25
773
Depreciation & amort.
−0
−0
−0
EBIT
−21
25
773
Net financials
−0
−0
−2
Profit before tax
−21
25
771
Tax
−0
1
172
Net profit
−21
24
599
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
3
91
690
Equity
3
27
626
Long-term debt
0
0
0
Short-term debt
0
64
64
Total debt
0
64
64
Financial ratios
5-year trend
EBITDA margin
26.7%
This company
15.8%
Market median
+69% vs market
2023
2025
Equity ratio
90.7%
This company
38.2%
Market median
+137% vs market
2023
2025
Return on equity
95.7%
This company
18.4%
Market median
+420% vs market
2023
2025
Net profit margin
20.7%
This company
8.1%
Market median
+156% vs market
2023
2025
Asset turnover
4.20×
This company
1.12×
Market median
+275% vs market
2023
2025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
More on OSENTI AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
